Abstract
Pulmonary arterial hypertension (PAH) is a group of diseases with an increase of pulmonary artery pressure (PAP) and pulmonary vascular resistance. Here, the effects of safflower injection, a preparation of Chinese herbs, was investigated in a monocrotaline (MCT)-induced PAH rat model. PAP, carotid artery pressure (CAP), and the right ventricular hypertrophy index (RVHI) increased in the PAH group, while safflower injection was able to inhibit this increase to similar levels as observed in the normal group. The arteriole wall of the lungs and cardiac muscle were thickened and edema was observed in the PAH group, while these pathologies were improved in the herb-treated group in a dose-dependent manner. MCT treatment induced proliferation of pulmonary artery smooth muscle cells (PASMCs), which was inhibited by safflower injection in a dose-dependent manner. Our experimental results demonstrated that safflower injection can regulate pulmonary arterial remodeling through affecting the expression of connective tissue growth factor, transforming growth factor-β, integrin, collagen or fibronectin, which subsequently affected the thicknesses of the arteriole walls of the lungs and cardiac muscle, and thereby benefits the control of PAH. This means safflower injection improved the abnormalities in PAP, CAP and RVHI, and pulmonary arterial remodeling through regulation of remodeling factors.
Funding source: Key Projects of Medical and Health Technology Program in Hangzhou
Award Identifier / Grant number: 2014Z12
Acknowledgment
We thank Prof. Stijn van der Veen (Zhejiang University, China) for proof reading of our manuscript.
Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by the Key Projects of Medical and Health Technology Program in Hangzhou (No. 2014Z12).
Conflict of interest statement: The authors declare no conflict of interest.
References
1. Sahni, S, Ojrzanowski, M, Majewski, S, Talwar, A. Pulmonary arterial hypertension: a current review of pharmacological management. Pneumonol Alergol Pol 2016;84:47–61. https://doi.org/10.5603/PiAP.a2015.0084.Search in Google Scholar PubMed
2. Aldemir, M, Emren, SV, Balçık, Ç, Onrat, E, Gürsoy, M. Primary pulmonary arterial hypertension with preserved right ventricular function leads to lower extremity venous insufficiency. Vascular 2018;26:183–8. https://doi.org/10.1177/1708538117723201.Search in Google Scholar PubMed
3. Schermuly, RT, Ghofrani, HA, Wilkins, MR, Grimminger, F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 2011;8:443–55. https://doi.org/10.1038/nrcardio.2011.87.Search in Google Scholar PubMed PubMed Central
4. Bourgeois, A, Lambert, C, Habbout, K, Ranchoux, B, Paquet-Marceau, S, Trinh, I, et al.. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension. J Mol Med (Berl) 2018;96:223–35. https://doi.org/10.1007/s00109-017-1619-0.Search in Google Scholar PubMed
5. Vonk Noordegraaf, A, Chin, KM, Haddad, F, Hassoun, PM, Hemnes, AR, Hopkins, SR, et al.. Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J 2019;53. pii: 1801900. https://doi.org/10.1183/13993003.01900-2018.Search in Google Scholar PubMed PubMed Central
6. Farkas, L, Kolb, MRJ. A switch in TGF-β signaling explains contradictory findings in pulmonary arterial hypertension. Am J Respir Crit Care Med 2018;197:157–9. https://doi.org/10.1164/rccm.201708-1741ED.Search in Google Scholar PubMed
7. Lambers, C, Kornauth, C, Oberndorfer, F, Boehm, PM, Tamm, M, Klepetko, W, et al.. Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells. PLoS One 2018;13:e0205195. https://doi.org/10.1371/journal.pone.0205195.Search in Google Scholar PubMed PubMed Central
8. Pi, L, Fu, C, Lu, Y, Zhou, J, Jorgensen, M, Shenoy, V, et al.. Vascular endothelial cell-specific connective tissue growth factor (CTGF) is necessary for development of chronic hypoxia-induced pulmonary hypertension. Front Physiol 2018;9:138. https://doi.org/10.3389/fphys.2018.00138.Search in Google Scholar PubMed PubMed Central
9. Humbert, M, Guignabert, C, Bonnet, S, Dorfmüller, P, Klinger, JR, Nicolls, MR, et al.. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J 2019;53. pii: 1801887.10.1183/13993003.01887-2018Search in Google Scholar PubMed PubMed Central
10. Vaidya, B, Pangallo, M, Ruffenach, G, Cunningham, CM, Perron, JC, Kolluru, S, et al.. Advances in treatment of pulmonary arterial hypertension: patent review. Expert Opin Ther Pat 2017;27:907–18. https://doi.org/10.1080/13543776.2017.1313232.Search in Google Scholar PubMed
11. Galiè, N, Humbert, M, Vachiery, JL, Gibbs, S, Lang, I, Torbicki, A, et al.. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016;37:67–119. https://doi.org/10.1093/eurheartj/ehv317.Search in Google Scholar PubMed
12. Lee, YS, Byun, J, Kim, JA, Lee, JS, Kim, KL, Suh, YL, et al.. Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung. Exp Mol Med 2005;37:27–35. https://doi.org/10.1038/emm.2005.4.Search in Google Scholar PubMed
13. He, H, Yang, X, Shi, M, Zeng, X, Yang, J, Wu, L, et al.. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats. J Pharm Pharmacol 2008;60:115–23. https://doi.org/10.1211/jpp.60.1.0015.Search in Google Scholar PubMed
14. Li, L, Dong, P, Hou, C, Cao, F, Sun, S, He, F, et al.. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats. J Ethnopharmacol 2016;186:224–33. https://doi.org/10.1016/j.jep.2016.04.004.Search in Google Scholar PubMed
15. He, RL, Wu, ZJ, Liu, XR, Gui, LX, Wang, RX, Lin, MJ. Calcineurin/NFAT signaling modulates pulmonary artery smooth muscle cell proliferation, migration and apoptosis in monocrotaline-induced pulmonary arterial hypertension rats. Cell Physiol Biochem 2018;49:172–89. https://doi.org/10.1159/000492852.Search in Google Scholar PubMed
16. Nogueira-Ferreira, R, Vitorino, R, Ferreira, R, Henriques-Coelho, T. Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach. Pulm Pharmacol Ther 2015;35:8–16. https://doi.org/10.1016/j.pupt.2015.09.007.Search in Google Scholar PubMed
17. Ramazani, Y, Knops, N, Elmonem, MA, Nguyen, TQ, Arcolino, FO, van den Heuvel, L, et al. Connective tissue growth factor (CTGF) from basics to clinics. Matrix Biol 2018;68–69:44–66. https://doi.org/10.1016/j.matbio.2018.03.007.Search in Google Scholar PubMed
18. Cheng, JC, Chang, HM, Leung, PCK. Connective tissue growth factor mediates TGF-β1-induced low-grade serous ovarian tumor cell apoptosis. Oncotarget 2017;8:85224–33. https://doi.org/10.18632/oncotarget.19626.Search in Google Scholar PubMed PubMed Central
19. Lin, CH, Yu, MC, Tung, WH, Chen, TT, Yu, CC, Weng, CM, et al.. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway. Biochim Biophys Acta 2013;1833:2823–33. https://doi.org/10.1016/j.bbamcr.2013.07.016.Search in Google Scholar PubMed
20. Yang, K, Gao, K, Hu, G, Wen, Y, Lin, C, Li, X. CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer. Onco Targets Ther 2016;9:7285–95. https://doi.org/10.2147/OTT.S108929.Search in Google Scholar PubMed PubMed Central
21. Rosenkranz, S. Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options. Clin Res Cardiol 2015;104:197–207. https://doi.org/10.1007/s00392-014-0765-4.Search in Google Scholar PubMed
22. Tielemans, B, Delcroix, M, Belge, C, Quarck, R. TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension. Drug Discov Today 2019;24:703–16. https://doi.org/10.1016/j.drudis.2018.12.001.Search in Google Scholar PubMed
23. Zhu, R, He, L, Xu, J, Zhang, Y, Hu, Y. Changes of TGF-β1 and CTGF in rats with increased blood flow-induced pulmonary artery hypertension. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2012;37:1013–20. https://doi.org/10.3969/j.issn.1672-7347.2012.10.008.Search in Google Scholar PubMed
24. Humphries, JD, Byron, A, Humphries, MJ. Integrin ligands at a glance. J Cell Sci 2006;119(pt 19):3901–3. https://doi.org/10.1242/jcs.03098.Search in Google Scholar PubMed PubMed Central
25. Bai, Y, Li, ZX, Zhao, YT, Liu, M, Wang, Y, Lian, GC, et al.. PCPA protects against monocrotaline-induced pulmonary arterial remodeling in rats: potential roles of connective tissue growth factor. Oncotarget 2017;8:111642–55. https://doi.org/10.18632/oncotarget.22882.Search in Google Scholar PubMed PubMed Central
26. Dai, HY, Zheng, M, Lv, LL, Tang, RN, Ma, KL, Liu, D, et al.. The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes. J Cell Biochem 2012;113:293–301. https://doi.org/10.1002/jcb.23355.Search in Google Scholar PubMed
27. Umesh, A, Paudel, O, Cao, YN, Myers, AC, Sham, JS. Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension. J Vasc Res 2011;48:525–37. https://doi.org/10.1159/000329593.Search in Google Scholar PubMed PubMed Central
28. Ebnerasuly, F, Hajebrahimi, Z, Tabaie, SM, Darbouy, M. Effect of simulated microgravity conditions on differentiation of adipose derived stem cells towards fibroblasts using connective tissue growth factor. Iran J Biotechnol 2017;15:241–51. https://doi.org/10.15171/ijb.1747.Search in Google Scholar PubMed PubMed Central
29. Golob, MJ, Wang, Z, Prostrollo, AJ, Hacker, TA, Chesler, NC. Limiting collagen turnover via collagenase-resistance attenuates right ventricular dysfunction and fibrosis in pulmonary arterial hypertension. Physiol Rep 2016;4. pii: e12815.10.14814/phy2.12815Search in Google Scholar PubMed PubMed Central
30. Safdar, Z, Tamez, E, Chan, W, Arya, B, Ge, Y, Deswal, A, et al. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail 2014;2:412–21. https://doi.org/10.1016/j.jchf.2014.03.013.Search in Google Scholar PubMed PubMed Central
31. Fan, XF, Wang, XR, Yuan, GS, Wu, DH, Hu, LG, Xue, F, et al.. Effect of safflower injection on endoplasmic reticulum stress-induced apoptosts in rats with hypoxic pulmonary hypertension. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2012;28:561–7. https://doi.org/10.13459/j.cnki.cjap.2012.06.005.Search in Google Scholar
© 2020 Walter de Gruyter GmbH, Berlin/Boston
